When medicine is written in code, how do you market the cure? A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms? In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape. Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: ¿ What digital therapeutics are - and how they differ from wellness apps. ¿ Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks. ¿ How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs. ¿ Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health. ¿ The role of AI, wearables, and telemedicine in scaling digital care. ¿ Strategic frameworks for commercialization, adoption, and measuring success. Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded. Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Subba Rao ChagantiHe has a master's in business administration and over fifty-two years of experience in Pharmaceutical marketing. His experience encompasses all facets of the industry, from sales and sales management to product management and overseeing overall marketing activities. He has experience in both domestic and international marketing, as well as within the Indian and multinational sectors.He also taught a course on Advertising and Brand Management as an adjunct professor at Gitam Institute of Foreign Trade (now part of Gitam University) in Visakhapatnam for a few years and a course on Marketing as a visiting faculty member at Jawaharlal Nehru Technological University (JNTU) in Hyderabad.He lives in Farmington, Connecticut, USA, and can be reached at: subbarao.chaganti@gmail.com.Here is a list of his publications:1. Pharmaceutical Marketing in India: Concepts, Cases, Strategy2. Game Plans for Post-GATT Era: Action Agenda of the Indian Pharmaceutical Industry3. Compete or Forfeit: Strategies for Sustainable Competitive Advantage in the Pharma Product Patents Era4. Pharmaceutical Marketing in India for Today and Tomorrow - 25th Anniversary Edition5. Bullseyes and Blunders: Lessons from 100 Cases in Pharma Marketing6. Digital Pharma Marketing Playbook: Winning With the New Rules of Engagement7. Cracking the Generics Code: Your Single-Source Success Manual for Winning in Multi-Source Product Markets8. Reimagine Pharma Marketing: Make It Future-Proof!9. Brand Positioning in Pharma10. Transactional to Transformational Marketing in Pharma: The Science of Why and The Art of How11. A to Z of Pharmaceutical Marketing: World's First and Only Encyclopedia in Two Volumes12. The Synergy of Minds: Human+AI Orchestrating the Pharma MarketingRevolution13. Design Thinking for Pharma14. The Pharma Product Manager: Navigating the Digital Frontier15. Sentiment Analysis for Pharma Marketers16. Whispering to AI: Prompt Engineering for Pharma Brand Managers17. Storytelling in Pharma Marketing18. Beyond the Molecule: The Art and Science of Metaphors That Matter19. The Voices Within: Your Body Speaks, When Your Organs Tell Their Own Stories20. Pharma Archetypes: The Science of Meaningful Healthcare Marketing
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 52882357-n
Anzahl: Mehr als 20 verfügbar
Anbieter: BargainBookStores, Grand Rapids, MI, USA
Paperback or Softback. Zustand: New. Code to Cure: Digital Therapeutics and the Future of Pharma. Book. Bestandsnummer des Verkäufers BBS-9789347311147
Anbieter: PBShop.store US, Wood Dale, IL, USA
HRD. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bestandsnummer des Verkäufers L0-9789347311147
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 52882357
Anzahl: Mehr als 20 verfügbar
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. When medicine is written in code, how do you market the cure?A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms?In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape.Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: - What digital therapeutics are - and how they differ from wellness apps.- Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks.- How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs.- Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health.- The role of AI, wearables, and telemedicine in scaling digital care.- Strategic frameworks for commercialization, adoption, and measuring success.Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded.Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9789347311147
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
HRD. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bestandsnummer des Verkäufers L0-9789347311147
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 52882357-n
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 52882357
Anzahl: Mehr als 20 verfügbar
Anbieter: AussieBookSeller, Truganina, VIC, Australien
Hardcover. Zustand: new. Hardcover. When medicine is written in code, how do you market the cure?A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms?In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape.Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: - What digital therapeutics are - and how they differ from wellness apps.- Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks.- How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs.- Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health.- The role of AI, wearables, and telemedicine in scaling digital care.- Strategic frameworks for commercialization, adoption, and measuring success.Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded.Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Bestandsnummer des Verkäufers 9789347311147
Anzahl: 1 verfügbar
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
Hardcover. Zustand: new. Hardcover. When medicine is written in code, how do you market the cure?A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms?In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape.Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: - What digital therapeutics are - and how they differ from wellness apps.- Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks.- How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs.- Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health.- The role of AI, wearables, and telemedicine in scaling digital care.- Strategic frameworks for commercialization, adoption, and measuring success.Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded.Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Bestandsnummer des Verkäufers 9789347311147
Anzahl: 1 verfügbar